摘要
目的:观察中风回言胶囊治疗中风失语的疗效。方法:将符合纳入标准的180例患者随机分为两组:治疗组120例服中风回言胶囊4粒,每日3次;对照组60例服华佗再造丸8g,每日3次,两组均以30天为1个疗程,每位患者均在治疗当天及1个疗程结束后按《汉语失语检查法》评分,根据评分结果比较两组治疗前后评分均值、疗效以及治疗组疗效与病变类型、失语程度、年龄、性别、病程等的关系。结果:两组治疗后评分均值与治疗前比较差异均有显著性,但以治疗组更为明显;治疗组治愈率及总有效率均明显高于对照组;治疗组的疗效与疾病性质、患者性别无明显关系,但与患者年龄大小、病程长短、失语轻重有关。结论:中风回言胶囊疗效明显,无论对脑出血或脑梗死患者,均有确切疗效;但病程越短疗效越好,提示病情稳定后应及时治疗。
Objective： To observe therapeutic effect of Zhongfeng Huiyan Capsule on apoplectic aphasia. Methods： 180 cases who conformed to the criteria were randomly divided into two groups. The treatment group （n=120） were treated by Zhongfeng Huiyan Capsule, 4 capsules once, 3 times each day; and the control group （n=60） by Huatuo Zaizao Bolus, 8g once, 3 times each day, 30 days constituting one course. The scores in each patient were counted at the first day and the end of the treatment based on The Chinese Aphasia Examination. Mean scores before and after treatment and therapeutic effects between the two groups were compared, and the relations of the therapeutic effect and lesion types, aphasic extent, age, gender, duration of illness were investigated. Results： There were significant differences before and after treatment in mean score in the two groups with more obvious changes in the treatment group. The treatment group was significantly superior to the control group in the cured rate and the effective rate,the therapeutic effect in the treatment group was not related with the tpye of disease and the gender. However, younger patients or the patients with shorter duration of disease and milder aphasia would achieve more higher cured rate. Conclusion： Zhongfeng Huiyan Capsule has obvious therapeutic effect for the patients of cerebral hemorrhage or cerebral infarction. The shorter duration of illness, the better the therapeutic effect.
出处
《中医杂志》
CSCD
北大核心
2005年第10期756-758,共3页
Journal of Traditional Chinese Medicine
基金
河南省1999年科技攻关项目(991170619)
